GLP-1 supplements and patches: are they GLP-1 medicines?

The name "GLP-1" belongs to a gut hormone and to a class of medicines. Cells in the gut release the hormone when a person eats². The medicines are built to switch on its receptor directly and in a lasting way².

A PharmEasy listing shows that a tablet sold in India as "Glp 1mg" contains glimepiride, a type 2 diabetes medicine, and not a GLP-1 medicine³. Like all sulfonylureas, glimepiride can cause severe low blood sugar, its US label says⁴.

In Ireland, a test of a sample of seized patches sold as semaglutide found none¹. The finding covers patches seized in Ireland, not patches sold in India.

Patches that claim a medicine

In 2025, most GLP-1 products that Ireland's Health Products Regulatory Authority (HPRA) detained were sold as semaglutide or tirzepatide⁵. They came mainly as drops (27,329 items) or microneedle patches with tiny needles (17,170 items)⁵. The HPRA says that such drops and patches are not approved treatments, and that no evidence supports their use⁵. It warns that prescription medicines from unregulated sources may be unsafe, ineffective or fake, and could seriously harm health¹. It urges people who obtained such medicines to stop using them immediately, and to seek advice from a healthcare professional if they have concerns¹.

Two skin researchers argued in 2000 that only compounds under 500 daltons, a unit for weighing molecules, are absorbed through the skin⁶. The US label gives semaglutide's molecular weight as about 4,114 daltons⁷. Microneedles are designed to pierce the outer layer of the skin instead⁸. A 2024 laboratory study of a semaglutide microneedle patch used rats, 4 in each group, and its authors plan pigs next, not people⁸.

Plant-based "natural GLP-1" patches

A 2026 study looked at 24 such patches sold in the US⁹. They listed an average of 7 plant or nutrient ingredients, most often berberine (a plant substance), glutamine, cinnamon and pomegranate⁹. None posted a certificate of analysis (a laboratory report of the contents), and many used deceptive advertising⁹. US law requires a dietary supplement to be swallowed, so the authors call all these patches illegal in the US⁹. In India, FSSAI's rules describe a health supplement as a product taken by mouth¹⁰. The sources used here do not say how Indian law treats a patch.

Pharmacy Times, a US journal for pharmacists, lists the common booster ingredients: berberine, chromium picolinate, resveratrol, dietary fibre, green tea extract and probiotics². It says that some may have modest effects on metabolism, but none should be considered equivalent to a GLP-1 medicine².

In a 2026 meta-analysis that pooled 23 trials of berberine, body weight fell by 0.88 kg more on average than in the comparison (control) groups¹¹. The authors ask future trials to report the purity, potency and amount of berberine used, and to deal with common biases¹¹.

For safety, Pharmacy Times cites reviews of berberine and blood fats, such as cholesterol². In those trials, it says, side effects were generally mild, and no serious adverse events were reported². They included constipation, gas (wind), nausea, headache and raised liver enzymes². The journal also advises caution with chromium for people on insulin or another medicine that lowers blood sugar, because the effects can add up². If you take a prescribed medicine for weight or diabetes, talk to your doctor before you stop it or add a supplement².

The same journal says fibre may be the most reasonable of these ingredients to discuss as an add-on, though not as a substitute for a GLP-1 medicine². Fibres such as psyllium (isabgol) may promote fullness and support modest weight reduction alongside eating fewer calories². Its fibre cautions cover bloating, gas, enough water, and taking fibre apart from other medicines so that they are still absorbed².

Regions: STEP 1 (global trial), US label, Indian government, Ireland's HPRA, a US study and news report, global berberine trials, FSSAI^{1,7,9,10,11,12,13}.

STEP 1 was a 68-week trial in 1,961 adults without diabetes, funded by Novo Nordisk¹². Body weight changed by −14.9 % on semaglutide 2.4 mg and −2.4 % on placebo, as a share of starting weight, or −15.3 kg against −2.6 kg¹². The trials differ in people, dose and length, and neither figure predicts one person's result. Our guide to managing GLP-1 side effects covers the medicines' own side effects.

In India, FSSAI regulates a supplement as food¹⁰. For a GLP-1 medicine, a government explainer from the Press Information Bureau (PIB) advises consulting a qualified medical specialist and obtaining it only on prescription¹³.

A health supplement may not claim, on its label or in advertising, to treat or prevent any disease unless FSSAI permits it¹⁰. On 8 October 2026, FSSAI was reported to have issued notices over the health claims of a protein supplement with "GLP" in its name¹⁵. The product was marketed to people taking GLP-1 medicines, and the notices do not amount to a final finding¹⁵. According to the report, FSSAI said that the brand name could create a potentially misleading association with these medicines¹⁵.

The report adds that calling a supplement high in protein describes what it contains¹⁵. Saying that it preserves muscle during a therapy may suggest a specific health benefit¹⁵. For food during treatment, see our guide on what to eat on semaglutide.

PharmEasy, an Indian online pharmacy, lists Mounjaro and every semaglutide brand as Schedule H, and says Mounjaro cannot be sold over the counter^16,17. A government warning reported in March 2026 says generic semaglutide needs a registered medical practitioner's prescription; a health-ministry release names specialists for weight-loss drugs^18,19. Semaglutide tablets have a guide of their own.

In April 2026, Reuters reported that Haryana's drug regulator had seized more than 260 suspected counterfeit Mounjaro pens²⁰. Officials quoted in the report said the pens were sold through an online marketplace; Reuters could not verify either claim²⁰.

1. Read the ingredient list, but do not treat it as proof. Booster ingredients generally do not directly activate GLP-1 receptors to the same extent as the medicines². A medicine named on a patch is not proof either: Ireland's test of patches sold as semaglutide found none¹. A US journal reports a US FDA warning that many weight-loss products sold as supplements may contain hidden drug ingredients².
2. Get any GLP-1 medicine with a prescription, through a regulated channel. Treat one sold without a prescription as a warning sign. Suspected counterfeit Mounjaro pens were reported seized in Haryana²⁰.
3. On a supplement, check the FSSAI logo and licence number, and know what they mean. Every packaged food in India must show both on its label²¹. Under those food rules, a supplement may not claim to treat or prevent a disease unless FSSAI permits it¹⁰.
4. Tell your doctor about every supplement you take. A US pharmacy journal advises pharmacists to check for liver disease, pregnancy and drug interactions before a person takes berberine².

If you react to a patch, a supplement or an unregulated medicine, see a doctor. In an emergency, call 112, India's single emergency number²². Also report a suspected side effect of a medicine to India's Pharmacovigilance Programme (PvPI)^23,24. Its helpline is 1800 180 3024, on working days²³.

Glimepiride can cause low blood sugar, and the UK's National Health Service (NHS) lists signs such as sweating, shaking and dizziness^4,25. For a person with diabetes, the NHS advises quick treatment, such as a small glass of fruit juice²⁶. Then tell the doctor. If someone may have very low blood sugar and is not responding normally, or is unconscious, call 112^22,26. Give an unconscious person nothing to eat or drink²⁶.

What is the most natural GLP-1 supplement? Booster supplements generally do not directly activate GLP-1 receptors to the same extent as the medicines². The most natural GLP-1 is the body's own, which the gut releases when a person eats². Berberine lowered body weight by 0.88 kg against control groups across 23 trials, and a US pharmacy journal links it to constipation, nausea and raised liver enzymes^2,11. Tell your doctor if you take it².

Do GLP-1 patches work? No evidence in the sources used here shows that they do. For patches sold as semaglutide or tirzepatide, Ireland's regulator says no evidence supports their use, and its test of a sample found no semaglutide^1,5. Plant-based patches had no posted laboratory reports in a 2026 US study⁹.

What GLP-1 medicines are available in India? Mounjaro (tirzepatide) reached India on 20 March 2025, and Wegovy (semaglutide 2.4 mg) on 24 June 2025^27,28. Ozempic, for type 2 diabetes, launched on 12 December 2025^29,30. Generic semaglutide followed in March 2026, and Rybelsus tablets are sold for type 2 diabetes^31,32. Most of the generic approvals that we read in the minutes of CDSCO, India's drug regulator, are for type 2 diabetes³³. Liraglutide and dulaglutide, older medicines in the class, are still sold, a market report says³⁴. We found no Indian approval or launch of the Wegovy pill as of 20 October 2026³⁵. Our guide to GLP-1 brands and generics in India lists them.

Which brand of GLP-1 is best? This page recommends no brand. The choice belongs to you and your doctor; our comparison of which GLP-1 medicine is best for weight loss sets out the trial results.

Do I need a prescription for a GLP-1 medicine in India? Yes. India's government advises the public to obtain GLP-1 medicines only on prescription¹³, and PharmEasy lists Mounjaro and every semaglutide brand as Schedule H^16,17.

Is semaglutide safe for weight loss? Semaglutide has known risks, and a doctor has to judge whether it suits you. The US label warns about acute pancreatitis and acute gallbladder disease⁷. The US label's boxed warning says semaglutide caused thyroid C-cell tumours in rodents; whether it does so in humans is not known⁷. Our page on who should not take semaglutide lists the people who must avoid it.

Talk to a Zelta specialist about whether a GLP-1 medicine is right for you.